Barbara Idzior−Waluś

1.4k total citations
41 papers, 622 citations indexed

About

Barbara Idzior−Waluś is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Barbara Idzior−Waluś has authored 41 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Barbara Idzior−Waluś's work include Lipoproteins and Cardiovascular Health (16 papers), Cancer, Lipids, and Metabolism (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Barbara Idzior−Waluś is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Cancer, Lipids, and Metabolism (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Barbara Idzior−Waluś collaborates with scholars based in Poland, United Kingdom and Finland. Barbara Idzior−Waluś's co-authors include M. Mattock, V A Koivisto, Peter R. Ebeling, Judith Stephenson, Michele Muggeo, J. H. Fuller, Małgorzata Waluś‐Miarka, Jacek Sieradzki, Anna Zdzienicka and A. F. Żarnecki and has published in prestigious journals such as Diabetes Care, European Heart Journal and Diabetologia.

In The Last Decade

Barbara Idzior−Waluś

37 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Idzior−Waluś Poland 12 309 205 122 94 81 41 622
Mary Mamakeesick Canada 15 232 0.8× 114 0.6× 196 1.6× 53 0.6× 159 2.0× 23 698
James E. Lang United States 11 167 0.5× 166 0.8× 60 0.5× 52 0.6× 40 0.5× 12 497
Yuri Moriyama Japan 13 241 0.8× 415 2.0× 110 0.9× 33 0.4× 67 0.8× 14 771
J. S. Davies United Kingdom 11 254 0.8× 127 0.6× 161 1.3× 35 0.4× 28 0.3× 21 587
Canan Ersoy Türkiye 16 315 1.0× 178 0.9× 65 0.5× 46 0.5× 81 1.0× 90 768
IF Godsland United Kingdom 13 329 1.1× 57 0.3× 106 0.9× 96 1.0× 137 1.7× 20 689
MK Garg India 16 313 1.0× 96 0.5× 47 0.4× 56 0.6× 70 0.9× 39 585
Fen Lee Hew Malaysia 12 414 1.3× 290 1.4× 227 1.9× 80 0.9× 59 0.7× 25 785
Celeste C. Thomas United States 12 127 0.4× 203 1.0× 28 0.2× 71 0.8× 51 0.6× 45 579
Bjørn Gunnar Nedrebø Norway 13 472 1.5× 267 1.3× 50 0.4× 99 1.1× 30 0.4× 30 853

Countries citing papers authored by Barbara Idzior−Waluś

Since Specialization
Citations

This map shows the geographic impact of Barbara Idzior−Waluś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Idzior−Waluś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Idzior−Waluś more than expected).

Fields of papers citing papers by Barbara Idzior−Waluś

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Idzior−Waluś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Idzior−Waluś. The network helps show where Barbara Idzior−Waluś may publish in the future.

Co-authorship network of co-authors of Barbara Idzior−Waluś

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Idzior−Waluś. A scholar is included among the top collaborators of Barbara Idzior−Waluś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Idzior−Waluś. Barbara Idzior−Waluś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waluś‐Miarka, Małgorzata, Anna Polus, & Barbara Idzior−Waluś. (2024). Aortic valve and arterial calcification in patients with familial hypercholesterolemia. Kardiologia Polska. 82(2). 144–155. 2 indexed citations
2.
Totoń‐Żurańska, Justyna, Paweł Wołkow, Maria Kapusta, et al.. (2023). Targeted sequencing of a gene panel in patients with Familial Hypercholesterolemia from Southern Poland. Polskie Archiwum Medycyny Wewnętrznej. 133(6). 1 indexed citations
3.
Idzior−Waluś, Barbara & Małgorzata Waluś‐Miarka. (2015). Is now the time for probiotics in diabetes management?. Polskie Archiwum Medycyny Wewnętrznej. 125(11). 797–798. 2 indexed citations
4.
Idzior−Waluś, Barbara & Małgorzata Waluś‐Miarka. (2013). Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies. Clinical Diabetology. 2(1). 23–29.
5.
Rynkiewicz, Andrzej, Barbara Cybulska, Maciej Banach, et al.. (2013). Postępowanie w heterozygotycznej hipercholesterolemii rodzinnej. Stanowisko Forum Ekspertów Lipidowych. Family Medicine & Primary Care Review. 51–54. 2 indexed citations
6.
Rynkiewicz, Andrzej, Barbara Cybulska, Maciej Banach, et al.. (2013). [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].. PubMed. 71(1). 107–11. 4 indexed citations
7.
Rynkiewicz, Andrzej, Barbara Cybulska, Maciej Banach, et al.. (2013). Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. Journal of clinical lipidology. 7(3). 217–221. 24 indexed citations
8.
Idzior−Waluś, Barbara. (2013). Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. Medical Science Monitor. 19. 1167–1172. 23 indexed citations
9.
Miarka, Przemysław, Barbara Idzior−Waluś, Marek Kuźniewski, et al.. (2011). Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clinical and Experimental Nephrology. 15(3). 424–429. 11 indexed citations
10.
Waluś‐Miarka, Małgorzata, Marek Sanak, Barbara Idzior−Waluś, et al.. (2011). A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland. Molecular Biology Reports. 39(5). 5181–5186. 3 indexed citations
11.
Idzior−Waluś, Barbara, Marek Sanak, Jerzy Starzyk, Danuta Czarnecka, & Małgorzata Waluś‐Miarka. (2009). [Autosomal dominant hypercholesterolemia - underrecognised diagnostic and clinical problem].. PubMed. 67(9). 1015–22. 2 indexed citations
12.
Idzior−Waluś, Barbara & Małgorzata Waluś‐Miarka. (2009). Algorithms in the management of lipid disorders in diabetes. Clinical Diabetology. 10(5). 180–185.
13.
Waluś‐Miarka, Małgorzata, Danuta Czarnecka, Kalina Kawecka−Jaszcz, et al.. (2005). [Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].. PubMed. 62(1). 46–8. 1 indexed citations
14.
Chaturvedi, Nish, et al.. (2005). Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross‐sectional nested case–control study. Journal of Internal Medicine. 258(5). 450–459. 30 indexed citations
15.
Idzior−Waluś, Barbara, Jacek Sieradzki, Gert M. Kostner, et al.. (2005). Familial lecithin-cholesterol acyltransferase deficiency: Biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family. Atherosclerosis. 185(2). 413–420. 9 indexed citations
16.
Idzior−Waluś, Barbara. (2001). [Familial LCAT deficiency].. PubMed. 58(10). 919–23. 1 indexed citations
17.
Mattock, M., P. Cavallo‐Perin, Barbara Idzior−Waluś, et al.. (2001). Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine. 18(1). 59–67. 33 indexed citations
18.
Idzior−Waluś, Barbara, et al.. (2001). Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine. 18(10). 786–796. 41 indexed citations
19.
Idzior−Waluś, Barbara, et al.. (2000). Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X. European Journal of Clinical Investigation. 30(10). 871–878. 74 indexed citations
20.
Rywik, S, et al.. (1985). [Monitoring trends in cardiovascular disease incidence and mortality and their determinants: "Pol-Monica" longitudinal study. II. Materials and methods].. PubMed. 42(2). 256–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Mamakeesick Breakdown of academic impact, for papers by James E. Lang Breakdown of academic impact, for papers by Yuri Moriyama Breakdown of academic impact, for papers by J. S. Davies Breakdown of academic impact, for papers by Canan Ersoy Breakdown of academic impact, for papers by IF Godsland Breakdown of academic impact, for papers by MK Garg Breakdown of academic impact, for papers by Fen Lee Hew Breakdown of academic impact, for papers by Celeste C. Thomas Breakdown of academic impact, for papers by Bjørn Gunnar Nedrebø
Rankless by CCL
2026